• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10622
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Restenosis (4576)
Event Date 08/14/2023
Event Type  Injury  
Event Description
Synergy china registry.It was reported that unstable angina and restenosis occurred.In (b)(6) 2022, the subject presented with myocardial infarction was referred for cardiac catheterization.The target lesion was located in the proximal left anterior descending (lad) artery with 100% stenosis and was 30 mm long, with a reference vessel diameter of 2.75 mm.The target lesion was treated with pre-dilatation and placement of 2.75 mm x 32 mm synergy stent system.Following post-dilatation, the residual stenosis was noted to be 0%.Seven days later, the subject was discharged on aspirin and ticagrelor.In (b)(6) 2023, the subject was diagnosed with unstable angina pectoris and was hospitalized for further treatment.Eight days later, the subject was referred for coronary angiography which revealed 85% stenosis noted in proximal lad extending up to middle lad which had previously placed study device was treated with percutaneous coronary intervention.Post intervention, residual stenosis was 0%.Additionally, medication was given to treat the event.Two days later, the event was considered to be recovered/resolved and the subject was discharged on aspirin and ticagrelor.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18779375
MDR Text Key336233997
Report Number2124215-2024-08826
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/26/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/16/2023
Device Model Number10622
Device Catalogue Number10622
Device Lot Number0027907974
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/06/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/16/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization;
Patient Age54 YR
Patient SexMale
-
-